Sherlock Biosciences’ COVID-19 test got FDA emergency use approval. It’s the first CRISPR-based coronavirus diagnostic kit approved, and can detect the virus in one hour. The company’s been using CRISPR technology for around a year to diagnose diseases. [Built In Boston]
Wayfair stock hit all-time high. Due to the pandemic, it’s seen a big jump in active customers. As of 4 p.m. last Tuesday, it had a market cap of $15.8 billion. [Boston Business Journal]
Jellyfish raised $12M. The engineering management startup analyzes engineering signals and contextual business data to help provide visibility into how teams operate. Accel and Wing Venture Capital led the funding. [Built In Boston]
Hyannis Port Research and Preservica pledged not to lay off employees. Many companies have laid people off due to the COVID-19 pandemic. But these two Boston companies wanted to assure their employees that their jobs were secure. [BostInno]
Pillar VC and Petri launched Breakout workshop. It’s a six-week program meant for people who want to start a company. The virtual course begins on June 11, with applications due by May 22. [Built In Boston]
